Onderneming Adverum Biotechnologies, Inc.
Aandelen
ADVM
US00773U2078
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,19 USD | -2,13% | -18,96% | +22,08% |
21/03 | Adverum Biotechnologies dient een aanvraag in voor $200 miljoen gemengde Shelf | MT |
19/03 | ADVERUM BIOTECHNOLOGIES, INC. : RBC Capital Markets vindt het aandeel niet inspirerend | ZM |
Vakgebied
Aantal werknemers: 121
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15-06-20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12-12-22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/01 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30-10-19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21-08-23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06-01-22 |
Corporate Officer/Principal | - | 25-06-20 | |
Dena House
HRO | Human Resources Officer | - | 01-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 16-04-20 | |
Clarence Machado
CHM | Chairman | 60 | 14-03-17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15-06-20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01-05-19 |
C. Nicholson
BRD | Director/Board Member | 68 | 03/11 |
Mark Lupher
BRD | Director/Board Member | 53 | 01-05-19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19-02-21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09-12-20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 17-03-22 |
Soo Hong
BRD | Director/Board Member | 52 | 17-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 754 915 | 20 327 441 ( 97,94 %) | 0 | 97,94 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,08% | 191 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers ADVM
- Onderneming Adverum Biotechnologies, Inc.